- Trials with a EudraCT protocol (61)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
61 result(s) found for: Syncope.
Displaying page 1 of 4.
EudraCT Number: 2013-004919-43 | Sponsor Protocol Number: STOP-VD | Start Date*: 2014-05-14 | |||||||||||||||||||||
Sponsor Name:SOD Medicina e Cardiologia Geriatrica, Centro per lo Studio della Sincope - Università degli Studi di Firenze-AOUCareggi | |||||||||||||||||||||||
Full Title: Suspension of vasoactive drugs in reflex vasodepressive syncope: a randomized controlled trial | |||||||||||||||||||||||
Medical condition: Vasodepressive neuroreflex syncope | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000284-14 | Sponsor Protocol Number: | Start Date*: 2016-01-05 |
Sponsor Name:University of Calgary | ||
Full Title: Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects | ||
Medical condition: Vasovagal Syncope | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002262-37 | Sponsor Protocol Number: ATP1 | Start Date*: 2004-10-27 |
Sponsor Name:Newcastle Hospitals Trust | ||
Full Title: Adenosine testing in the diagnosis of unexplained syncope: A pilot study | ||
Medical condition: Syncope | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002160-14 | Sponsor Protocol Number: 20160516 | Start Date*: 2016-11-22 |
Sponsor Name:St. Antonius Hospital | ||
Full Title: 68Ga-DOTA-NOC PET/CT for the imaging of disease activity in neurologic and cardiac sarcoidosis. | ||
Medical condition: Sarcoidosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003697-52 | Sponsor Protocol Number: SYNCOPE-2021-V1 | Start Date*: 2020-09-16 | |||||||||||
Sponsor Name:Helsinki University Hospital | |||||||||||||
Full Title: Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastases | |||||||||||||
Medical condition: Rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002580-85 | Sponsor Protocol Number: 3d | Start Date*: 2005-08-08 |
Sponsor Name:Rigshospitalet | ||
Full Title: Acute haemodynanic effects of Treatment with ACE inhibitores in patients with severe Aortic Stenosis | ||
Medical condition: Aortic valve stenosis is a reduction of the aortic valve orifice to a degree where emptying of the left ventricule is compromised. The two major causes for aortic valve stenosis is calcific valve d... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002860-86 | Sponsor Protocol Number: 2007/099 | Start Date*: 2007-06-26 |
Sponsor Name:Radboud University Nijmegen Medical Centre | ||
Full Title: The adenosine receptor; a new pharmacological tool in the treatment of sepsis. | ||
Medical condition: Systemic inflammatory response | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001285-38 | Sponsor Protocol Number: 1366-0021 | Start Date*: 2021-12-10 | |||||||||||
Sponsor Name:Boehringer Ingelheim bv Netherlands | |||||||||||||
Full Title: Randomised, double-blind, placebo-controlled and parallel group trial to investigate the effects of two doses (up-titration to a fixed dose regimen) of oral BI 685509 on portal hypertension after 2... | |||||||||||||
Medical condition: portal hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) BE (Completed) IT (Prematurely Ended) AT (Prematurely Ended) DE (Prematurely Ended) FR (Completed) ES (Completed) DK (Prematurely Ended) PT (Prematurely Ended) HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006897-60 | Sponsor Protocol Number: mis131206 | Start Date*: 2007-03-29 | |||||||||||
Sponsor Name:Leids Universitair Medisch Centrum | |||||||||||||
Full Title: Does Misoprostol facilitate the insertion of an Intra Uterine device (IUD), both copper-containing as well as levonorgestrel-releasing, with nulli- and multipara? | |||||||||||||
Medical condition: Insertion of Intra Uterine Device (IUD) It is known that insertion of IUD sometimes fail or happen to be complicated (eg. by syncope, perforation of cervix or uterus or by creating a false passage... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000994-39 | Sponsor Protocol Number: BRD 06/2-D | Start Date*: 2008-05-27 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Nantes | |||||||||||||
Full Title: Evaluation de l'intérêt d'un traitement par hydroquinidine pour la prise en charge des patients atteints d'un syndrome de Brugada à risque rythmique élevé et implantés d'un défibrillateur | |||||||||||||
Medical condition: Patients with syndroma of Brugada who have an automatic implantable cardiac defibrillator | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005688-36 | Sponsor Protocol Number: SCIVF2021 | Start Date*: 2022-09-19 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation: An open label, randomized crossover pilot trial | ||
Medical condition: Short-coupled idiopathic ventricular fibrillation is a rare syndrome and subtype of idiopathic ventricular fibrillation that is characterized by ventricular fibrillation or polymorphic ventricular ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004604-37 | Sponsor Protocol Number: NL55891.078.15 | Start Date*: 2017-02-17 |
Sponsor Name:Erasmus University Medical Center | ||
Full Title: Aspirin provocation of patients with Systemic Mastocytosis | ||
Medical condition: Systemic mastocytosis is a myeloproliferative disorder in which there is an accumulation of aberrant mast cells. It has various subtypes, ranging from indolent to aggressive mastocytosis. Symptoms ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002336-17 | Sponsor Protocol Number: REDUCe_2017-05-22 | Start Date*: 2017-08-06 |
Sponsor Name:Department of Clinical Sciences, Danderyd Hospital, Karolinska Intitutet | ||
Full Title: Randomized Evaluation of Decreased Usage of betablocCkErs after myocardial infarction in the SWEDEHEART registry REDUCe SWEDEHEART | ||
Medical condition: Long-term treatment with beta-blockers in patients with myocardial infarction and preserved ejection fraction. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) EE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-014582-51 | Sponsor Protocol Number: MO-90020714 | Start Date*: 2010-03-26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Faculty of Medicine, Technische Universität München | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Pilot study - sequential combination therapy using selective immunoglobulin apheresis and omalizumab in patients with severe atopic dermatitis and elevated total IgE levels | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with severe Atopic dermatitis and total IgE-level > 700 IU/ml (potentially associated with bronchial asthma and/or allergic rhinitis) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005255-27 | Sponsor Protocol Number: DX-2930-04 | Start Date*: 2016-11-30 | |||||||||||
Sponsor Name:Dyax Corp. (an indirect, wholly-owned subsidiary of Shire plc.) | |||||||||||||
Full Title: HELP Study ExtensionTM: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of DX-2930 for Prevention Against Acute Attacks of Hereditary Angioedema (HAE) | |||||||||||||
Medical condition: Type I and Type II Hareditary Angioedema (HAE) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004823-20 | Sponsor Protocol Number: TAK-743-3001 | Start Date*: 2021-07-22 | |||||||||||
Sponsor Name:Takeda Development Center Americas (TDCA) | |||||||||||||
Full Title: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema with Normal C1-Inhibitor (C1-INH) | |||||||||||||
Medical condition: non-histaminergic angioedema with normal C1-INH | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) PL (Completed) NL (Completed) IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000020-32 | Sponsor Protocol Number: CV131-176 | Start Date*: 2005-02-16 |
Sponsor Name:Bristol Myers Squibb International Corporation | ||
Full Title: The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension | ||
Medical condition: Severe Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006177-88 | Sponsor Protocol Number: FARM65KNKY | Start Date*: 2008-01-24 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years where thrombolysis is initiated within 3 hours afte... | |||||||||||||
Medical condition: acute ischemic stroke | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019014-25 | Sponsor Protocol Number: Istrokepilot | Start Date*: 2010-07-27 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: A PROSPECTIVE, RANDOMISED, OPEN, BLINDED EVALUATION, ASCENDING-DOSE, PILOT TRIAL OF IMATINIB IN ACUTE ISCHAEMIC STROKE (I-STROKE/pilot) | ||
Medical condition: Acute ischaemic stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001141-32 | Sponsor Protocol Number: 09.0111p | Start Date*: 2011-04-28 |
Sponsor Name:Isala klinieken department Cardiology | ||
Full Title: Catheter ablation versus Amiodarone to pRevent Future ventricular tachycardia Episodes in patients with a defibrillator and a history of a myocardial infarction | ||
Medical condition: The primary purpose of this randomized study is the assessment of recurrences of sustained VT and ICD therapy for VT or VF after appropriate ICD therapy (ATP or shock) in patients with a history of... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
